Seeking Alpha

Illumina (ILMN -1.2%) says its Board unanimously rejects Roche's (RHHBY.PK +2.3%) revised...

Illumina (ILMN -1.2%) says its Board unanimously rejects Roche's (RHHBY.PK +2.3%) revised $51/share takeover offer, claiming the offer still undervalues ILMN and does not adequately reflect the company's singular position in an industry poised for extraordinary growth. (earlier)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs